- Home
- ASLE vs LXEO Comparison
ASLE vs LXEO Comparison
Compare ASLE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- LXEO
- Stock Information
- Founded
- ASLE 2008
- LXEO 2017
- Country
- ASLE United States
- LXEO United States
- Employees
- ASLE N/A
- LXEO N/A
- Industry
- ASLE Industrial Specialties
- LXEO
- Sector
- ASLE Consumer Discretionary
- LXEO
- Exchange
- ASLE Nasdaq
- LXEO Nasdaq
- Market Cap
- ASLE 277.0M
- LXEO 257.0M
- IPO Year
- ASLE N/A
- LXEO 2023
- Fundamental
- Price
- ASLE $8.63
- LXEO $4.79
- Analyst Decision
- ASLE Hold
- LXEO Strong Buy
- Analyst Count
- ASLE 2
- LXEO 7
- Target Price
- ASLE $7.00
- LXEO $15.29
- AVG Volume (30 Days)
- ASLE 602.4K
- LXEO 279.8K
- Earning Date
- ASLE 08-06-2025
- LXEO 08-14-2025
- Dividend Yield
- ASLE N/A
- LXEO N/A
- EPS Growth
- ASLE N/A
- LXEO N/A
- EPS
- ASLE 0.13
- LXEO N/A
- Revenue
- ASLE $350,583,000.00
- LXEO N/A
- Revenue This Year
- ASLE $9.98
- LXEO N/A
- Revenue Next Year
- ASLE $8.15
- LXEO N/A
- P/E Ratio
- ASLE $70.13
- LXEO N/A
- Revenue Growth
- ASLE N/A
- LXEO N/A
- 52 Week Low
- ASLE $4.53
- LXEO $1.45
- 52 Week High
- ASLE $9.12
- LXEO $11.96
- Technical
- Relative Strength Index (RSI)
- ASLE 65.59
- LXEO 54.88
- Support Level
- ASLE $8.74
- LXEO $4.50
- Resistance Level
- ASLE $9.12
- LXEO $5.00
- Average True Range (ATR)
- ASLE 0.33
- LXEO 0.33
- MACD
- ASLE -0.05
- LXEO -0.02
- Stochastic Oscillator
- ASLE 32.88
- LXEO 58.76
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.